Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy. Kmezic I, Press R, Glenewinkel H, Doppler K, et al. J Neuroimmunol 2024;389:578326.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kmezic I, Press R, Glenewinkel H, Doppler K, et al. Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy. J Neuroimmunol 2024;389:578326.
PMID: 38422690